Glaukos Innovation to be Highlighted at the 2025 American Academy of Ophthalmology Annual Meeting
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases...